Subscribe
Subscribe for the Newsletter
Mobile Navigation
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Experience
Market Research
Directory
Close
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Focusing on Patient Compliance
N
Nice Insight
Apr 6, 2017
PTV-M01-17-NS-011
Formulation
Drug Delivery
PA TV (video)
Brian Wilson, Technical Development Manager, SPI Pharma
Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Explore
About Us
Nice Insight
That's Nice
Reach Our Team
Contact Us
Advertise
LinkedIn
My Account
Login
Sign up
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.
Privacy Policy
Terms And Conditions
Related Content
High-Concentration
High-Concentration Biologics Are Redefining Subcutaneous Delivery
Pharma's Almanac
PAO-07-26-PA-08
Jul 15, 2026
Drug Delivery
Intracellular Delivery: Reaching Targets Beyond the Cell Surface
David Alvaro, Ph.D.
Pharma's Almanac
PAO-07-26-PA-07
Jul 14, 2026
LAI Formulation
The Formulation Science Behind Extended Drug Release
Pharma's Almanac
PAO-07-26-PA-03
Jul 9, 2026
Drug–Device
Designing Formulations Around Devices Rather Than Vice Versa
Pharma's Almanac
PAO-07-26-PA-04
Jul 7, 2026
Next-Gen Delivery
Beyond Lipid Nanoparticles: The Search for Next-Generation Delivery Platforms
Pharma's Almanac
PAO-07-26-PA-06
Jul 6, 2026
LAIs
The Long View: How Extended-Duration Therapies Are Reshaping Patient Care
Pharma's Almanac
PAO-07-26-PA-01
Jul 1, 2026
Bioavailability
AustinPx Expands KinetiSol™ Technology Commercial Access through Thermo Fisher Scientific Collaboration
AustinPx
PR-06-26-03
Jun 30, 2026
LNP Strategy
Building Better RNA Medicines Through Smarter LNP Formulation Strategy
Aula Al Muslim, Ph.D.
Recipharm Advanced Bio
PAO-06-26-CL-03
Jun 22, 2026
Pathfinder
Depot Injection vs. Implantable Drug Delivery: Which Long-Acting Delivery Strategy Is Better?
Pharma's Almanac
PAO-26-PF-12
Jun 19, 2026
Peptides
The Resurgence of Peptide Drugs in the Age of Precision Medicine
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-26-PA-16
May 15, 2026
Partnership
The Solubility Company and Persist AI Unveil Strategic Partnership to Bridge the Data Gap in AI-Driven Drug Formulation
The Solubility Company
PR-05-26-02
May 13, 2026
Oligo Delivery
Expanding the Reach of Oligonucleotide Drugs Through Delivery Innovation
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-26-PA-06
May 5, 2026
Previous slide
Next slide
